Evaluation of peripheral blood count recovery as predictors of clinical outcome during induction chemotherapy in childhood acute lymphoblastic leukemia

Background Accurate monitoring of bone marrow recovery after induction chemotherapy in pediatric with acute lymphoblastic leukemia (ALL) is crucial. Reticulocyte parameters may predict hematopoietic regeneration earlier than platelet and neutrophil counts, but data in Egyptian children are lacking. Objectives To investigate the potential role of different hematopoietic parameters in predicting recovery in postchemotherapy ALL pediatric Egyptian patients. Patients and methods This prospective cohort investigation enrolled 80 children (aged 18 or younger) with B- or T-cell ALL commencing induction chemotherapy. Peripheral blood samples were drawn at 4-day intervals over a maximum of 32 days. Key metrics included reticulocyte percentage, absolute reticulocyte count, absolute neutrophil count, and platelet count, with “recovery” established as three consecutive days above predetermined levels. Statistical comparisons of recovery durations were performed using nonparametric ANOVA (significance set at P <0.05). Results All measured recovery durations exhibited statistically significant differences ( P =0.015 for reticulocyte percentage, P =0.003 for absolute reticulocyte count, P =0.001 for platelets, and P =0.002 for absolute neutrophil count). Importantly, after a median follow-up of 30 months, the 3-year event-free survival stood at 75.0%, and overall survival at 85.0%, with median event-free survival and overall survival yet to be reached. Factors such as poor Day 8’s steroid response and older age consistently predicted poorer outcomes. Conclusion For Egyptian children with ALL undergoing chemotherapy, reticulocyte measurements demonstrate a significantly earlier return to normal compared with platelet counts, positioning them as valuable, rapid indicators of bone marrow recovery. Furthermore, poor early steroid response and older age are critical prognostic markers influencing long-term survival.

Authors

Institutions

Publication Details

Journal
The Egyptian Journal of Haematology
Published
2025-10-01
DOI
https://doi.org/10.4103/ejh.ejh_118_25
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of peripheral blood count recovery as predictors of clinical outcome during induction chemotherapy in childhood acute lymphoblastic leukemia

Manal Mohamed Easa, Eman Abdelaziz
The Egyptian Journal of Haematology
Inflammatory Biomarkers in Disease Prognosis
article

Evaluation of peripheral blood count recovery as predictors of clinical outcome during induction chemotherapy in childhood acute lymphoblastic leukemia

Manal Mohamed Easa, Eman Abdelaziz
article en

Abstract

Background Accurate monitoring of bone marrow recovery after induction chemotherapy in pediatric with acute lymphoblastic leukemia (ALL) is crucial. Reticulocyte parameters may predict hematopoietic regeneration earlier than platelet and neutrophil counts, but data in Egyptian children are lacking. Objectives To investigate the potential role of different hematopoietic parameters in predicting recovery in postchemotherapy ALL pediatric Egyptian patients. Patients and methods This prospective cohort investigation enrolled 80 children (aged 18 or younger) with B- or T-cell ALL commencing induction chemotherapy. Peripheral blood samples were drawn at 4-day intervals over a maximum of 32 days. Key metrics included reticulocyte percentage, absolute reticulocyte count, absolute neutrophil count, and platelet count, with “recovery” established as three consecutive days above predetermined levels. Statistical comparisons of recovery durations were performed using nonparametric ANOVA (significance set at P <0.05). Results All measured recovery durations exhibited statistically significant differences ( P =0.015 for reticulocyte percentage, P =0.003 for absolute reticulocyte count, P =0.001 for platelets, and P =0.002 for absolute neutrophil count). Importantly, after a median follow-up of 30 months, the 3-year event-free survival stood at 75.0%, and overall survival at 85.0%, with median event-free survival and overall survival yet to be reached. Factors such as poor Day 8’s steroid response and older age consistently predicted poorer outcomes. Conclusion For Egyptian children with ALL undergoing chemotherapy, reticulocyte measurements demonstrate a significantly earlier return to normal compared with platelet counts, positioning them as valuable, rapid indicators of bone marrow recovery. Furthermore, poor early steroid response and older age are critical prognostic markers influencing long-term survival.

The Egyptian Journal of HaematologyVol. 50(4)
Zagazig University (EG)
Good health and well-being
Openalex Percentile: Top 29%
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.